Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE Jr.

Exp Hematol. 2012 Dec;40(12):974-982.e1. doi: 10.1016/j.exphem.2012.08.002. Epub 2012 Aug 10.

PMID:
22885125
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomes.

Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, Greer JP, Jiang A, Kassim AA, Lu P, Schuening F, Yoder SM, Rock MT, Crowe JE Jr.

Bone Marrow Transplant. 2011 Mar;46(3):436-42. doi: 10.1038/bmt.2010.127. Epub 2010 May 31.

PMID:
20577222
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells.

Engelhardt BG, Crowe JE Jr.

Curr Top Microbiol Immunol. 2010;341:121-46. doi: 10.1007/82_2010_24.

PMID:
20563712
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.

Bremm M, Huenecke S, Lehrnbecher T, Ponstingl E, Mueller R, Heinze A, Bug G, Quaiser A, Kapinsky M, Brehm C, Bader P, Schneider G, Klingebiel T, Koehl U.

J Immunol Methods. 2011 Oct 28;373(1-2):36-44. doi: 10.1016/j.jim.2011.07.018. Epub 2011 Aug 3.

PMID:
21839739
[PubMed - indexed for MEDLINE]
5.

Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.

Li Q, Zhai Z, Xu X, Shen Y, Zhang A, Sun Z, Liu H, Geng L, Wang Y.

Leuk Res. 2010 Sep;34(9):1158-68. doi: 10.1016/j.leukres.2010.03.017. Epub 2010 Apr 20.

PMID:
20409584
[PubMed - indexed for MEDLINE]
6.

CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.

Pastore D, Delia M, Mestice A, Carluccio P, Perrone T, Gaudio F, Curci P, Rossi AR, Ricco A, Specchia G.

Biol Blood Marrow Transplant. 2012 Jun;18(6):887-93. doi: 10.1016/j.bbmt.2011.10.039. Epub 2011 Nov 4.

PMID:
22062803
[PubMed - indexed for MEDLINE]
7.

[Relationship between CD4(+)CD25(+) regulatory T cells, IL-2, TGF-beta and acute graft-versus host disease after allogeneic hematopoietic stem cell transplantation].

Niu YY, Ma LM, Zhou Y, Ren RR.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):735-9. Chinese.

PMID:
20561440
[PubMed - indexed for MEDLINE]
8.

Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD.

Fujioka T, Tamaki H, Ikegame K, Yoshihara S, Taniguchi K, Kaida K, Kato R, Inoue T, Nakata J, Ishii S, Soma T, Okada M, Ogawa H.

Bone Marrow Transplant. 2013 Jun;48(6):859-64. doi: 10.1038/bmt.2012.232. Epub 2012 Nov 19.

PMID:
23165499
[PubMed - indexed for MEDLINE]
9.

Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation.

Ngoma AM, Ikeda K, Hashimoto Y, Mochizuki K, Takahashi H, Sano H, Matsumoto H, Noji H, Saito S, Kikuta A, Ogawa K, Ohtsuka M, Abe M, Nollet KE, Ohto H.

Int J Hematol. 2012 Jan;95(1):86-94. doi: 10.1007/s12185-011-0976-7. Epub 2011 Dec 14.

PMID:
22160825
[PubMed - indexed for MEDLINE]
10.

Characterization of CD3+CD4-CD8- (double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation.

Ye H, Chang Y, Zhao X, Huang X.

Transpl Immunol. 2011 Dec;25(4):180-6. doi: 10.1016/j.trim.2011.08.004. Epub 2011 Sep 2.

PMID:
21911061
[PubMed - indexed for MEDLINE]
11.

High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.

Lu SY, Liu KY, Liu DH, Xu LP, Huang XJ.

Clin Exp Immunol. 2011 Aug;165(2):264-77. doi: 10.1111/j.1365-2249.2011.04418.x. Epub 2011 Jun 2.

PMID:
21635226
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease.

Magenau JM, Qin X, Tawara I, Rogers CE, Kitko C, Schlough M, Bickley D, Braun TM, Jang PS, Lowler KP, Jones DM, Choi SW, Reddy P, Mineishi S, Levine JE, Ferrara JL, Paczesny S.

Biol Blood Marrow Transplant. 2010 Jul;16(7):907-14. doi: 10.1016/j.bbmt.2010.02.026. Epub 2010 Mar 17.

PMID:
20302964
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Expression of CD30 in patients with acute graft-versus-host disease.

Chen YB, McDonough S, Hasserjian R, Chen H, Coughlin E, Illiano C, Park IS, Jagasia M, Spitzer TR, Cutler CS, Soiffer RJ, Ritz J.

Blood. 2012 Jul 19;120(3):691-6. doi: 10.1182/blood-2012-03-415422. Epub 2012 Jun 1.

PMID:
22661699
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Recovery of CMV-specific CD8+ T cells and Tregs after allogeneic peripheral blood stem cell transplantation.

Pastore D, Delia M, Mestice A, Perrone T, Carluccio P, Gaudio F, Giordano A, Rossi AR, Ricco A, Leo M, Liso V, Specchia G.

Biol Blood Marrow Transplant. 2011 Apr;17(4):550-7. doi: 10.1016/j.bbmt.2010.04.011. Epub 2010 May 10.

PMID:
20457268
[PubMed - indexed for MEDLINE]
15.

[Difference between FOXP3 gene expressions in donor grafts with or without acute graft-versus-host disease].

Wang ZD, Feng SZ, Zhou SY, Wang M, Zhou Z, Zhai WJ, Han MZ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1215-20. Chinese.

PMID:
17204197
[PubMed - indexed for MEDLINE]
16.

[Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].

Yang K, Fan ZP, Liu QF, Zhang Y.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Apr;28(4):537-41. Chinese.

PMID:
18495584
[PubMed - indexed for MEDLINE]
Free Article
17.

Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response.

Fondi C, Nozzoli C, Benemei S, Baroni G, Saccardi R, Guidi S, Nicoletti P, Bartolozzi B, Pimpinelli N, Santucci M, Bosi A, Massi D.

Biol Blood Marrow Transplant. 2009 Aug;15(8):938-47. doi: 10.1016/j.bbmt.2009.04.009. Epub 2009 Jun 10.

PMID:
19589483
[PubMed - indexed for MEDLINE]
18.

Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity.

Engelhardt BG, Jagasia SM, Crowe JE Jr, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M.

Blood. 2012 Mar 8;119(10):2417-21. doi: 10.1182/blood-2011-10-384750. Epub 2012 Jan 19.

PMID:
22262764
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin.

Wu KN, Emmons RV, Lisanti MP, Farber JL, Witkiewicz AK.

Cell Cycle. 2009 Nov 1;8(21):3601-5. Epub 2009 Nov 4.

PMID:
19838066
[PubMed - indexed for MEDLINE]
Free Article
20.

Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience.

Delia M, Pastore D, Mestice A, Carluccio P, Perrone T, Gaudio F, Ricco A, Sgherza N, Albano F, Specchia G.

Biol Blood Marrow Transplant. 2013 Mar;19(3):495-9. doi: 10.1016/j.bbmt.2012.11.015. Epub 2012 Nov 27.

PMID:
23200706
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk